Determination of anti-ds-DNA antibodies by three different methods: Comparison of sensitivity, specificity and correlation with lupus activity index (LAI)
Identifieur interne : 003079 ( Main/Exploration ); précédent : 003078; suivant : 003080Determination of anti-ds-DNA antibodies by three different methods: Comparison of sensitivity, specificity and correlation with lupus activity index (LAI)
Auteurs : A. G. Tzioufas [Grèce] ; C. Terzoglou [Grèce] ; E. D. Stavropoulos [Grèce] ; S. Athanasiadou [Grèce] ; H. M. Moutsopoulos [Grèce]Source :
- Clinical Rheumatology [ 0770-3198 ] ; 1990-06-01.
English descriptors
- KwdEn :
- Teeft :
- Arthritis rheum, Assay, Avidity, Avidity antibodies, Clinical activity, Clinical immunology laboratory, Crithidia, Crithidia assay, Crithidia assays, Crithidia lucilliae, Crithidia lucilliae assay, Diagnostic criteria, Different methods, Disease activity, Elisa, Elisa values, Enzyme immunoassay, Erythematosus, Farr, Farr assay, Farr assay values, High activity, High affinity antibodies, High avidity, Immunol, Lucilliae, Lupus, Lupus activity, Lupus activity index, Moderate activity, Optical density, Previous reports, Rheum, Rheumatoid arthritis, Room temperature, Sensitive method, Serum levels, Serum samples, Systemic lupus erythematosus.
Abstract
Summary: Ninety-seven sera, 58 from patients with SLE and 39 from patients with other autoimmune rheumatic diseases were tested for anti-ds-DNA antibody activity by ELISA, Farr, and Crithidia Lucilliae assays. Fifty-six per cent of the sera were positive by at least one method. Eighty per cent of the SLE population was positive by ELISA, 39% by Farr Assay and 33% by the Crithidia assay. Crithidia assay exhibited the greater specificity (100%) followed by the Farr Assay (97%) and the ELISA (80%). Sera positive by all methods showed a significantly higher mean value of the ELISA rates, than sera positive only by ELISA (p<0.001). When the SLE sera were analyzed according to disease activity, it was shown that ELISA and Farr Assay correlated well with the lupus activity index (LAI) (r<0.001). The SLE sera with the higher anti-ds-DNA concentration (sera positive by all 3 methods) did not correlate with LAI when tested by the Farr Assay (0.05
DOI: 10.1007/BF02031967
Url:
DOI: 10.1007/BF02031967
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002694
- to stream Istex, to step Curation: 002694
- to stream Istex, to step Checkpoint: 001E50
- to stream Main, to step Merge: 003148
- to stream Main, to step Curation: 003079
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Determination of anti-ds-DNA antibodies by three different methods: Comparison of sensitivity, specificity and correlation with lupus activity index (LAI)</title>
<author><name sortKey="Tzioufas, A G" sort="Tzioufas, A G" uniqKey="Tzioufas A" first="A. G." last="Tzioufas">A. G. Tzioufas</name>
</author>
<author><name sortKey="Terzoglou, C" sort="Terzoglou, C" uniqKey="Terzoglou C" first="C." last="Terzoglou">C. Terzoglou</name>
</author>
<author><name sortKey="Stavropoulos, E D" sort="Stavropoulos, E D" uniqKey="Stavropoulos E" first="E. D." last="Stavropoulos">E. D. Stavropoulos</name>
</author>
<author><name sortKey="Athanasiadou, S" sort="Athanasiadou, S" uniqKey="Athanasiadou S" first="S." last="Athanasiadou">S. Athanasiadou</name>
</author>
<author><name sortKey="Moutsopoulos, H M" sort="Moutsopoulos, H M" uniqKey="Moutsopoulos H" first="H. M." last="Moutsopoulos">H. M. Moutsopoulos</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6CB2F23E9DA1EDDB0E8190C128AE5D39DF85C0C3</idno>
<date when="1990" year="1990">1990</date>
<idno type="doi">10.1007/BF02031967</idno>
<idno type="url">https://api.istex.fr/ark:/67375/1BB-BVMNJFGK-M/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002694</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002694</idno>
<idno type="wicri:Area/Istex/Curation">002694</idno>
<idno type="wicri:Area/Istex/Checkpoint">001E50</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001E50</idno>
<idno type="wicri:doubleKey">0770-3198:1990:Tzioufas A:determination:of:anti</idno>
<idno type="wicri:Area/Main/Merge">003148</idno>
<idno type="wicri:Area/Main/Curation">003079</idno>
<idno type="wicri:Area/Main/Exploration">003079</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Determination of anti-ds-DNA antibodies by three different methods: Comparison of sensitivity, specificity and correlation with lupus activity index (LAI)</title>
<author><name sortKey="Tzioufas, A G" sort="Tzioufas, A G" uniqKey="Tzioufas A" first="A. G." last="Tzioufas">A. G. Tzioufas</name>
<affiliation wicri:level="1"><country xml:lang="fr">Grèce</country>
<wicri:regionArea>Clinical Immunology Laboratory, Department of Medicine, School of Medicine, University of Ioannina, 451 10, Ioannina</wicri:regionArea>
<wicri:noRegion>Ioannina</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Terzoglou, C" sort="Terzoglou, C" uniqKey="Terzoglou C" first="C." last="Terzoglou">C. Terzoglou</name>
<affiliation wicri:level="3"><country xml:lang="fr">Grèce</country>
<wicri:regionArea>Clinical Immunology Laboratory, Evangelismos Hospital, Athens</wicri:regionArea>
<placeName><settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Stavropoulos, E D" sort="Stavropoulos, E D" uniqKey="Stavropoulos E" first="E. D." last="Stavropoulos">E. D. Stavropoulos</name>
<affiliation wicri:level="1"><country xml:lang="fr">Grèce</country>
<wicri:regionArea>Clinical Immunology Laboratory, Department of Medicine, School of Medicine, University of Ioannina, 451 10, Ioannina</wicri:regionArea>
<wicri:noRegion>Ioannina</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Athanasiadou, S" sort="Athanasiadou, S" uniqKey="Athanasiadou S" first="S." last="Athanasiadou">S. Athanasiadou</name>
<affiliation wicri:level="3"><country xml:lang="fr">Grèce</country>
<wicri:regionArea>Clinical Immunology Laboratory, Evangelismos Hospital, Athens</wicri:regionArea>
<placeName><settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Moutsopoulos, H M" sort="Moutsopoulos, H M" uniqKey="Moutsopoulos H" first="H. M." last="Moutsopoulos">H. M. Moutsopoulos</name>
<affiliation wicri:level="1"><country xml:lang="fr">Grèce</country>
<wicri:regionArea>Clinical Immunology Laboratory, Department of Medicine, School of Medicine, University of Ioannina, 451 10, Ioannina</wicri:regionArea>
<wicri:noRegion>Ioannina</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Clinical Rheumatology</title>
<title level="j" type="abbrev">Clin Rheumatol</title>
<idno type="ISSN">0770-3198</idno>
<idno type="eISSN">1434-9949</idno>
<imprint><publisher>Springer-Verlag</publisher>
<pubPlace>London</pubPlace>
<date type="published" when="1990-06-01">1990-06-01</date>
<biblScope unit="volume">9</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="186">186</biblScope>
<biblScope unit="page" to="192">192</biblScope>
</imprint>
<idno type="ISSN">0770-3198</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0770-3198</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-ds-DNA</term>
<term>Crithidia Lucilliae</term>
<term>ELISA</term>
<term>Farr Assay</term>
<term>Lupus Activity</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Arthritis rheum</term>
<term>Assay</term>
<term>Avidity</term>
<term>Avidity antibodies</term>
<term>Clinical activity</term>
<term>Clinical immunology laboratory</term>
<term>Crithidia</term>
<term>Crithidia assay</term>
<term>Crithidia assays</term>
<term>Crithidia lucilliae</term>
<term>Crithidia lucilliae assay</term>
<term>Diagnostic criteria</term>
<term>Different methods</term>
<term>Disease activity</term>
<term>Elisa</term>
<term>Elisa values</term>
<term>Enzyme immunoassay</term>
<term>Erythematosus</term>
<term>Farr</term>
<term>Farr assay</term>
<term>Farr assay values</term>
<term>High activity</term>
<term>High affinity antibodies</term>
<term>High avidity</term>
<term>Immunol</term>
<term>Lucilliae</term>
<term>Lupus</term>
<term>Lupus activity</term>
<term>Lupus activity index</term>
<term>Moderate activity</term>
<term>Optical density</term>
<term>Previous reports</term>
<term>Rheum</term>
<term>Rheumatoid arthritis</term>
<term>Room temperature</term>
<term>Sensitive method</term>
<term>Serum levels</term>
<term>Serum samples</term>
<term>Systemic lupus erythematosus</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Summary: Ninety-seven sera, 58 from patients with SLE and 39 from patients with other autoimmune rheumatic diseases were tested for anti-ds-DNA antibody activity by ELISA, Farr, and Crithidia Lucilliae assays. Fifty-six per cent of the sera were positive by at least one method. Eighty per cent of the SLE population was positive by ELISA, 39% by Farr Assay and 33% by the Crithidia assay. Crithidia assay exhibited the greater specificity (100%) followed by the Farr Assay (97%) and the ELISA (80%). Sera positive by all methods showed a significantly higher mean value of the ELISA rates, than sera positive only by ELISA (p<0.001). When the SLE sera were analyzed according to disease activity, it was shown that ELISA and Farr Assay correlated well with the lupus activity index (LAI) (r<0.001). The SLE sera with the higher anti-ds-DNA concentration (sera positive by all 3 methods) did not correlate with LAI when tested by the Farr Assay (0.05</div>
</front>
</TEI>
<affiliations><list><country><li>Grèce</li>
</country>
<region><li>Attique (région)</li>
</region>
<settlement><li>Athènes</li>
</settlement>
</list>
<tree><country name="Grèce"><noRegion><name sortKey="Tzioufas, A G" sort="Tzioufas, A G" uniqKey="Tzioufas A" first="A. G." last="Tzioufas">A. G. Tzioufas</name>
</noRegion>
<name sortKey="Athanasiadou, S" sort="Athanasiadou, S" uniqKey="Athanasiadou S" first="S." last="Athanasiadou">S. Athanasiadou</name>
<name sortKey="Moutsopoulos, H M" sort="Moutsopoulos, H M" uniqKey="Moutsopoulos H" first="H. M." last="Moutsopoulos">H. M. Moutsopoulos</name>
<name sortKey="Stavropoulos, E D" sort="Stavropoulos, E D" uniqKey="Stavropoulos E" first="E. D." last="Stavropoulos">E. D. Stavropoulos</name>
<name sortKey="Terzoglou, C" sort="Terzoglou, C" uniqKey="Terzoglou C" first="C." last="Terzoglou">C. Terzoglou</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003079 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003079 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:6CB2F23E9DA1EDDB0E8190C128AE5D39DF85C0C3 |texte= Determination of anti-ds-DNA antibodies by three different methods: Comparison of sensitivity, specificity and correlation with lupus activity index (LAI) }}
This area was generated with Dilib version V0.6.33. |